Dimeric FcgR ectodomains as probes of the Fc receptor function of anti-influenza virus IgG

Bruce D. Wines, Hillary A. Vanderven, Sandra E. Esparon, Anne B. Kristensen, Stephen J. Kent, P. Mark Hogarth

Research output: Contribution to journalArticleResearchpeer-review

75 Citations (Scopus)


Ab-dependent cellular cytotoxicity, phagocytosis, and Ag presentation are key mechanisms of action of Abs arising in vaccine or naturally acquired immunity, as well of therapeutic mAbs. Cells expressing the low-affinity FcgRs (FcgRII or CD32 and FcgRIII or CD16) are activated for these functions when receptors are aggregated following the binding of IgG-opsonized targets. Despite the diversity of the Fc receptor proteins, IgG ligands, and potential responding cell types, the induction of all FcgR-mediated responses by opsonized targets requires the presentation of multiple Fc regions in close proximity to each other. We demonstrated that such "near-neighbor" Fc regions can be detected using defined recombinant soluble (rs) dimeric low-affinity ectodomains (rsFcgR) that have an absolute binding requirement for the simultaneous engagement of two IgG Fc regions. Like cell surface- expressed FcgRs, the binding of dimeric rsFcgR ectodomains to Ab immune complexes was affected by Ab subclass, presentation, opsonization density, Fc fucosylation, or mutation. The activation of an NK cell line and primary NK cells by human IgGopsonized influenza A hemagglutinin correlated with dimeric rsFcgRIIIa binding activity but not with Ab titer. Furthermore, the dimeric rsFcgR binding assay sensitively detected greater Fc receptor activity to pandemic H1N1 hemagglutinin after the swine influenza pandemic of 2009 in pooled human polyclonal IgG. Thus these dimeric rsFcgR ectodomains are validated, defined probes that should prove valuable in measuring the immune-activating capacity of IgG Abs elicited by infection or vaccination or experimentally derived IgG and its variants.

Original languageEnglish
Pages (from-to)1507-1516
Number of pages10
JournalJournal of Immunology
Issue number4
Publication statusPublished - 15 Aug 2016

Cite this